Korean J Prev Med.
2000 Dec;33(4):383-392.
The Cancer-preventive Potential of Panax ginseng: A Review of Human and Experimental Evidence
- Affiliations
-
- 1Department of Preventive Medicine, College of Medicine, Dong-A University.
- 2Department of Preventive Medicine, College of Medicine, Kosin University.
- 3Laboratory of Experimental Pathology, Korea Atomic Energy Research Institute, Korea Cancer Center Hospital.
- 4Unit of Chemoprevention, International Agency for Research on Cancer, Lyon,
France
Abstract
OBJECTIVE
We have reviewed the potential cancer preventive and other relevant
properties of Panax ginseng C. A. Meyer, which has been traditionally used as a natural
tonic in oriental countries.
DATA IDENTIFICATION AND STUDY SELECTION: Publications on Panax ginseng and its relation to
cancer were obtained from the Medline database (1983-2000) and by checking reference
lists to find earlier reports. The reports cover experimental models and human studies
on cancer-preventive activity, carcinogenicity and other beneficial or adverse effects. In
addition, possible mechanisms of chemoprevention by ginseng were also considered.
RESULTS
Published results from a cohort and two case-control studies in Korea suggest
that the intake of ginseng may reduce the risk of several types of cancer. When
ginseng was tested in animal models, a reduction in cancer incidence and multiplicity at
various sites was noted. Panax ginseng and its chemical constituents have been tested
for their inhibiting effect on putative carcinogenesis mechanisms (e.g., cell proliferation
and apoptosis, immunosurveillance, angiogenesis); in most experiments inhibitory effects
were found.
CONCLUSION
While Panax ginseng C. A. Meyer has shown cancer preventive effects
both in experimental models and in epidemiological studies, the evidence is currently not
conclusive as to its cancer-preventive activity in humans. The available evidence
warrants further research into the possible role of ginseng in the prevention of human
cancer and carcinogenesis.